RENATA share price
Renata PLC · Pharmaceuticals & Chemicals · Category A
Price
Closing prices, 19 Nov 2026 Live prices free with an account
- Previous close
- ৳423.80
- Day range
- 423.50 – 425.90
- Volume
- 17,007
- Turnover
- ৳72.1L
RENATA price over the last year
Daily closing prices from DSE, not adjusted for bonus or rights issues.
Reported earnings and NAV
| Period | EPS | NAV / share | NOCFPS |
|---|---|---|---|
| FY27 Q1 | 8.87 | 339.31 | 21.98 |
| FY26 Annual | 31.76 | 329.19 | 49.88 |
| FY26 Q3 | 6.81 | 320.02 | 22.40 |
| FY26 Q2 | 7.11 | 313.48 | 12.87 |
| FY26 Q1 | 6.47 | 312.01 | 12.61 |
| FY25 Annual | 19.36 | 305.49 | 41.16 |
| FY25 Q3 | 5.12 | 302.49 | 21.76 |
| FY25 Q2 | 5.64 | 297.23 | 3.60 |
Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.
Latest DSE announcements
-
The company has informed that it has expanded its commercial footprint into the European market with the launch of Amantadine HCl capsules in the Netherlands. The launch features Amantadine HCl 100 mg hard capsules, indicated for the symptomatic treatment of Parkinson's disease, supplied from Renata's EU-GMP-approved Rajendrapur General Facility as blister packs of 56 capsules. This product is marketed in Bangladesh by Renata PLC as Mantadin.
-
Trading of the shares of the company will resume on 16-Nov-2026.
-
Trading of the shares of the company will remain suspended on record date i.e., 15-Nov-2026.
-
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 11.11.2026 to 12.11.2026 and trading of the shares will remain suspended on record date i.e., 15.11.2026.
-
(Q1 Un-audited): Consolidated EPS was Tk. 8.87 for July-September 2026 as against Tk. 6.47 for July-September 2025. Consolidated NOCFPS was Tk. 21.98 for July-September 2026 as against Tk. 12.62 for July-September 2025. Consolidated NAV per share was Tk. 339.31 as on September 30, 2026 and Tk. 329.19 as on June 30, 2026. (cont.1)
-
(Cont. News of RENATA): Reasons for deviation: The Group's net profit for the quarter increased significantly compared to the corresponding quarter of the previous year, primarily attributable to revenue growth and a reduction in net finance expenses. The lower net finance expenses reflect the favorable impact of capital restructuring initiatives and prudent management of foreign exchange and interest rate risks. (cont.2)
Other Pharmaceuticals & Chemicals shares
| Ticker | Price | % | Turnover |
|---|---|---|---|
| ASIATICLABAsiatic Laboratories Limited | 116.70 | +1.83% | ৳16.3Cr |
| WATACHEMWata Chemicals Limited | 183.10 | +8.22% | ৳11.0Cr |
| SQURPHARMASquare Pharmaceuticals PLC. | 209.70 | -0.29% | ৳8.4Cr |
| ACMELABThe ACME Laboratories Limited | 77.50 | -3.73% | ৳3.2Cr |
| ORIONINFUOrion Infusion Ltd. | 202.80 | -0.44% | ৳2.9Cr |
| ACMEPLACME Pesticides Limited | 24.50 | -0.41% | ৳2.8Cr |
RENATA: common questions
What is RENATA's share price?
RENATA closed at ৳423.90 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), +0.10 (+0.02%) from the previous close of ৳423.80.
What is RENATA's 52-week high and low?
Between 23 Nov 2025 and 19 Nov 2026, RENATA traded as high as ৳488 and as low as ৳381.80 on DSE.
What is RENATA's P/E ratio?
At ৳423.90, RENATA's P/E ratio is 13.35, on its FY26 earnings per share of ৳31.76.
What dividend did RENATA declare?
For 2026, Renata PLC declared a 55% cash dividend. Percentages are of the ৳10 face value.
Which sector is RENATA in?
Renata PLC is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.
Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.